Literature DB >> 11150653

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

C Blais1, F Marceau, J L Rouleau, A Adam.   

Abstract

The purpose of the present review is to describe the place of endogenous kinins, mainly bradykinin (BK) and des-Arg(9)-BK in the kallikrein-kininogen-kinin system, to review and compare the different analytical methods reported for the assessment of endogenous kinins, to explain the difficulties and the pitfalls for their quantifications in biologic samples and finally to see how the results obtained by these methods could complement and extend the pharmacological evidence of their pathophysiological role.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11150653     DOI： 10.1016/s0196-9781(00)00348-x

Source DB:  PubMed          Journal:  Peptides        ISSN： 0196-9781            Impact factor:   3.750


  19 in total

Review 1.  Omapatrilat: a new tool for understanding metabolism of bradykinin at the endothelium level.

Authors:  M J Dumoulin; D Lamontagne; G Molinaro; A Adam
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 2.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Expression of the kallikrein/kinin system in human anterior segment.

Authors:  Jerry G Webb; Xiaofeng Yang; Craig E Crosson
Journal:  Exp Eye Res       Date:  2009-03-04       Impact factor: 3.467

4.  Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling.

Authors:  W Keith Jones; Guo-Chang Fan; Siyun Liao; Jun-Ming Zhang; Yang Wang; Neal L Weintraub; Evangelia G Kranias; Jo El Schultz; John Lorenz; Xiaoping Ren
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

5.  A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.

Authors:  Qing Ling Duan; Borzoo Nikpoor; Marie-Pierre Dube; Giuseppe Molinaro; Inge A Meijer; Patrick Dion; Daniel Rochefort; Judith Saint-Onge; Leah Flury; Nancy J Brown; James V Gainer; Jean L Rouleau; Angelo Agostoni; Massimo Cugno; Pierre Simon; Pierre Clavel; Jacky Potier; Bassem Wehbe; Seddik Benarbia; Julien Marc-Aurele; Jacques Chanard; Tatiana Foroud; Albert Adam; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2005-09-01       Impact factor: 11.025

6.  Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.

Authors:  Christian Drouet; Anik Désormeaux; Josée Robillard; Denise Ponard; Laurence Bouillet; Ludovic Martin; Gisèle Kanny; Denise-Anne Moneret-Vautrin; Jean-Luc Bosson; Jean-Louis Quesada; Margarita López-Trascasa; Albert Adam
Journal:  J Allergy Clin Immunol       Date:  2007-12-26       Impact factor: 10.793

7.  Kinin B1 receptors contributes to acute pain following minor surgery in humans.

Authors:  May Hamza; Xiao-Min Wang; Albert Adam; Jaime S Brahim; Janet S Rowan; Gilberto N Carmona; Raymond A Dionne
Journal:  Mol Pain       Date:  2010-02-13       Impact factor: 3.395

8.  Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry.

Authors:  Mark Lortie; Steven Bark; Roland Blantz; Vivian Hook
Journal:  Anal Biochem       Date:  2009-07-16       Impact factor: 3.365

9.  Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.

Authors:  Nathalie Lapointe; James N Tsoporis; Thomas G Parker; Charles Blais; Albert Adam; Dominique Rouleau; Graham Slaughter; Robert Clément; Christian E Deschepper; Jean L Rouleau
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

10.  Cathepsin K: a cysteine protease with unique kinin-degrading properties.

Authors:  Emmanuel Godat; Fabien Lecaille; Claire Desmazes; Sophie Duchêne; Enrico Weidauer; Paul Saftig; Dieter Brömme; Christophe Vandier; Gilles Lalmanach
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.